Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy

Weizhen Xu; Janss, Anna; Packer, Roger J.; Phillips, Peter; Goldwein, Joel; Moshang Jr., Thomas
April 2004
Neuro-Oncology;Apr2004, Vol. 6 Issue 2, p113
Academic Journal
Craniospinal radiation therapy (CSRT) combined with chemotherapy results in significant endocrine morbidity. Between 1987 and 1990, a trial using 18 Gy was conducted to treat 10 young children with medulloblastoma. There were 7 survivors. We compared the endocrine outcome in these children (group 18 Gy) to that of a comparable group treated with conventional doses of CSRT that ranged from 23 to 39 Gy (group CD). Both groups had an identical history of chemotherapy and tumor stage and were treated with recombinant growth hormone therapy (rhGH). The mean age of group 18 Gy at diagnosis was 4.0 years, and rhGH treatment was initiated in 6 children at age 9.2 years. Group CD (12 children) was diagnosed at a mean age of 5.8 years and rhGH started in 11 children at a mean age of 9.6 years. The dose of rhGH used in both groups was identical (0.3 mg/kg/wk). For group 18 Gy, adult heights and sitting heights (a mean standard deviation score of -1.01 ± 1.11 and -1.62 ± 1.16, respectively) were statistically greater (P < 0.05) than those for group CD (mean standard deviation score of -2.04 ± 0.83 and -3.16 ± 1.43, respectively). Moreover, adult heights of group 18 Gy were not different from midparental heights, unlike group CD, whose adult heights were less than midparental heights (P < 0.0001). Of other endocrine sequelae, 10 patients of the CD group were hypothyroid, 3 had adrenal insufficiency, 3 had hypogonadism, and 2 had early puberty. In contrast, within group 18 Gy, only 1 was hypothyroid (P = 0.006) and 1 had early puberty. We conclude that endocrine morbidity was significantly reduced with 18 Gy CSRT in young children with medulloblastoma.


Related Articles

  • Histone deacetylases expression in atypical teratoid rhabdoid tumors. Sredni, Simone; Halpern, Abby; Hamm, Christopher; Bonaldo, Maria; Tomita, Tadanori // Child's Nervous System;Jan2013, Vol. 29 Issue 1, p5 

    Purpose: Atypical teratoid rhabdoid tumors (ATRTs) are rare, highly malignant central nervous system tumors that occur during infancy and early childhood. Their poor outcome and resistance to conventional chemotherapies and radiotherapy, urges the development of new therapies. Recent studies...

  • Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review. Bogarin, Roberto; Steinbok, Paul // Child's Nervous System;Mar2009, Vol. 25 Issue 3, p273 

    Brain tumors are one of the most common types of solid neoplasm in children. As life expectancy of these patients has increased with new and improved therapies, the morbidities associated with the treatments and the tumor itself have become more important. One of the most common morbidities is...

  • Proton radiotherapy yielded good tumor control in pediatric medulloblastoma.  // Hem/Onc Today;10/25/2011, Vol. 12 Issue 20, p40 

    The article focuses on a study by Torunn I. Yock and colleagues which revealed that proton radiotherapy resulted in good tumor control and mitigation of neurocognitive and hearing effects in pediatric patients with medulloblastoma.

  • Medulloblastoma: clinicopathologic evaluation of 42 pediatric cases. Ertan, Yeşim; Sezak, Murat; Demirağ, Bengü; Kantar, Mehmet; Çetingül, Nazan; Turhan, Tuncer; Erşahin, Yusuf; Mutluer, Saffet; Anacak, Yavuz; Akalın, Taner // Child's Nervous System;Mar2009, Vol. 25 Issue 3, p353 

    The aim of this study was to assess the prognostic value of MIB-1 and p53 in the pediatric medulloblastoma group. Forty-two pediatric medulloblastoma cases diagnosed in a single institution during the past 10 years were evaluated. Follow-up data were available for 35 patients. The...

  • Medulloblastoma in children: a 32-year experience from a single institution. Canan Akyüz; Ali Varan; Serhan Küpeli; Nejat Akalan; Figen Söylemezoglu; Faruk Zorlu; Tezer Kutluk; Münevver Büyükpamukçu // Journal of Neuro-Oncology;Oct2008, Vol. 90 Issue 1, p99 

    Abstract  We retrospectively evaluated 203 patients newly diagnosed with medulloblastoma between 1975 and 2006. All patients underwent surgical resection and after surgery were treated with a combination of radiotherapy and chemotherapy. CCNU-based protocols were used in the early years,...

  • Analysis of the Effects of Breast Reconstruction in Breast Cancer Patients Receiving Radiotherapy after Mastectomy. Seong Hwan Kim; Jeong Min Kim; Sun Hyung Park; Sam Yong Lee // Archives of Plastic Surgery;2012, Vol. 39 Issue 3, p222 

    Background Immediate breast reconstruction after mastectomy and delayed breast reconstruction with post-supplementary treatment are the two types of breast reconstruction currently performed when treating breast cancer. Post-mastectomy radiation therapy (PMRT) not only reduces local recurrence...

  • Initial Management of Childhood Brain Tumors: Neurosurgical Considerations. Nejat, Farideh; El Khashab, Mostafa; Rutka, James T. // Journal of Child Neurology;Oct2008, Vol. 23 Issue 10, p1136 

    Intracranial tumors are the most common solid tumors in children. The infratentorial compartment will be the primary site for 60% to 70% of these tumors, including astrocytomas, medulloblastomas, and ependymomas. Several technological advancements have increased our knowledge of the cell biology...

  • Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma. Saito, Ryuta; Kumabe, Toshihiro; Sonoda, Yukihiko; Kanamori, Masayuki; Yamashita, Yoji; Watanabe, Mika; Tominaga, Teiji // Child's Nervous System;Sep2011, Vol. 27 Issue 9, p1399 

    Purpose: Treatment for medulloblastoma consists of surgical resection, radiation therapy, and chemotherapy. In Japan, ICE chemotherapy consisting of cisplatin, ifosfamide, and etoposide is one of the most common regimens. Here, we summarize the toxicity and efficacy of ICE chemotherapy and...

  • Primitive Cerebral Neuroectodermal Tumors Excluding Medulloblastomas: A Retrospective Study of 30 Cases. Mikaeloff, Yann; Raquin, Marie-Anne; Lellouch-Tubiana, Arielle; Terrier-Lacombe, Marie-José; Zerah, Michel; Bulteau, Christine; Habrand, Jean-Louis; Kalifa, Chantal // Pediatric Neurosurgery;Oct98, Vol. 29 Issue 4, p170 

    We present a retrospective study of 30 cases of primitive cerebral neuroectodermal tumors (PNET), excluding medulloblastomas, referred to us postoperatively for additional therapy to evaluate prognostic factors and treatment efficiency. The histologic types were: pinealoblastomas (n = 7);...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics